© 2021 MJH Life Sciences and Pharmacy Times. All rights reserved.
© 2021 MJH Life Sciences™ and Pharmacy Times. All rights reserved.
March 30, 2021
Women with obesity and polycystic ovarian syndrome (PCOS) have an increased risk of developing type 2 diabetes, according to a study presented virtually at ENDO 2021, the Endocrine Society's annual meeting.
March 29, 2021
The studies had a minimum follow-up period of 24 weeks and reported at least 1 event of breast cancer or benign breast neoplasm, which included 90,360 participants.
March 26, 2021
The STEP1 study included 1961 adults with a body mass index (BMI) of 27 or higher with at least 1 weight-related health condition, or a BMI of 30 or higher, without diabetes.
March 25, 2021
Although ART has helped improve the health of those with HIV, they are at a greater risk of developing complications related to chronic inflammation, such as cardiovascular disease.
March 24, 2021
New results show that non-Hispanic Black patients with COVID-19 and type 1 diabetes have an additional risk of diabetic ketoacidosis beyond the risk of having diabetes or being of minority status.
March 22, 2021
Black adults living in rural areas of the United States have experienced higher mortality rates due to diabetes, hypertension, heart disease, and stroke compared to white adults over the past 20 years, according to a research letter published in the Journal of the American College of Cardiology.
March 19, 2021
Study findings contradict a long-standing hypothesis that held the pancreas increases insulin production because the cells have already become insulin-resistant and blood sugar rises as a result.
March 17, 2021
Evidence demonstrates that overweight and obesity are risk factors for severe COVID-19.
March 15, 2021
Sodas have significantly high sugar levels and a lack of nutritional value, which may contribute to conditions that can lead to breast cancer.
March 12, 2021
Compared to the placebo group, patients with diabetes who received a 54-week course of treatment had higher levels of endogenous insulin secretion with no identified safety concerns.